Key Highlights
- Net loss per share was USD 1.29 against an estimate of a USD 0.39 loss.
- Net loss was USD 5.06 million, compared with Net Income of USD 4.68 million.
- Collaboration and license Revenue was USD 361,802, compared with USD 8.85 million.
- Cash was USD 3.74 million at September 30, 2026.
Palatin Technologies, Inc. (NASDAQ:PTN) reported a net loss of USD 5.06 million for the first quarter of fiscal 2027, the quarter ended September 30, 2026, compared with net income of USD 4.68 million in the prior-year quarter. Basic and diluted net loss per share was USD 1.29, compared with basic net income per share of USD 4.81 and diluted net income per share of USD 4.26, against an estimate of a USD 0.39 loss.
The company describes itself as a biopharmaceutical company developing first-in-class medicines based on peptide and small-molecule compounds that modulate the activity of the melanocortin receptor system.
Fiscal First Quarter Results
Collaboration and license revenue was USD 361,802, compared with USD 8.85 million in the prior-year quarter. Research and Development expense was USD 3.38 million, compared with USD 2.53 million, and general and administrative expense was USD 2.08 million, compared with USD 1.66 million.
Total operating expenses were USD 5.46 million, compared with USD 4.19 million. The loss from operations was USD 5.10 million, compared with income from operations of USD 4.66 million.
Investment income was USD 46,534, compared with USD 18,483, and interest expense was USD 1,690, compared with USD 2,002. Weighted average shares outstanding used for basic per-share figures were 3,922,464, compared with 971,650.
Balance Sheet
Cash and cash equivalents were USD 3.74 million at September 30, 2026, compared with USD 7.49 million at June 30, 2026. Accounts Receivable were USD 361,802, compared with USD 300,770, and total Assets were USD 4.72 million, compared with USD 8.52 million.
Total liabilities were USD 2.69 million, compared with USD 1.84 million, and current liabilities were USD 2.66 million, compared with USD 1.77 million. Accrued expenses were USD 1.17 million, compared with USD 504 thousand. Stockholders' Equity was USD 2.03 million, compared with USD 6.69 million, and the accumulated Deficit was USD 472.51 million, compared with USD 467.45 million.
Net cash used in financing activities was USD 10,001, compared with net cash provided of USD 328,200 in the prior-year quarter. The cover page reports 1,780,939 shares of common stock outstanding as of November 13, 2026.
Going Concern Disclosure
The filing states that, based on available cash and cash equivalents as of September 30, 2026, management concluded that substantial doubt exists about the company's ability to continue as a Going Concern for one year from the date the financial statements were issued.
The company states that it is evaluating strategies to obtain additional funding, including equity financing, issuing Debt or reducing planned expenses.
Palatin Technologies' Fiscal First Quarter 2027 Results in Review
Palatin Technologies reported fiscal first quarter 2027 collaboration and license revenue of USD 361,802 and a net loss of USD 5.06 million, or USD 1.29 per share. Operating expenses were USD 5.46 million.
Cash and cash equivalents were USD 3.74 million at September 30, 2026, and the filing includes a going concern disclosure alongside the company's funding evaluation.


_11_20_2026_14_55_23_118425.jpg)



Please wait processing your request...